AbbVie Inc. (ABBV) J.P. Morgan 43rd Annual Healthcare Conference (Transcript)

Key Points Company and Industry 1. Company: AbbVie Inc. (NYSE: ABBV) 2. Event: J.P. Morgan 43rd Annual Healthcare Conference 3. Date: January 15, 2025 4. Time: 11:15 AM ET 5. Participants: - Rob Michael - CEO - Scott Reents - Executive Vice President, CFO - Jeff Stewart - Executive Vice President, Chief Commercial Officer - Roopal Thakkar - Executive Vice President, Research & Development, Chief Scientific Officer - Chris Schott - J.P. Morgan [1] Core Views and Arguments 1. CEO Rob Michael's Performance: Rob Michael expresses satisfaction with the company's performance, noting that they are beating their top line by $1.8 billion and earnings are well ahead of expectations. 2. Focus on Growth Platform: Michael emphasizes the importance of executing the growth platform effectively, which he believes will provide a clear runway for growth for at least the next 8 years. 3. Pipeline Expansion: Michael also highlights the need to add to the pipeline to ensure sustained growth beyond the current period. [3][4] Other Important Points 1. Investor Perception: Michael acknowledges that investors may not fully appreciate the company's clear runway for growth over the next 8 years. 2. Management Team: The conference call features a broad swath of AbbVie's management team, indicating a collaborative approach to the company's strategy and execution. [3][4]